The genesis of hyperparathyroidism in uremia has turned out to be quit
e complex, involving low calcitriol, low ionized calcium, and possibly
direct effects of high phosphate as well as the action of local facto
rs and modifier genes determining the hyperplastic response of the gla
nd. Growth is initially polyclonal and later monoclonal. In addition,
the response of target tissues to parathyroid hormone (PTH) is attenua
ted (''PTH resistance''), and this may be due, at least in part, to di
minished phenotypic expression of PTH receptors. In a series of elegan
t studies, it has been shown that PTH acts not only on the classical t
arget organs of calcium homeostasis (ie, bone and kidney), but also on
nonclassical. The role of PTH excess in the genesis of several featur
es of the uremic syndrome, for example muscle dysfunction, cardiomyopa
thy, leukocyte and T-cell dysfunction or insulin secretion by pancreat
ic islet cells, has been established. These studies have borne out the
prediction that PTH is a ''uremic toxin.'' (C) 1995 by the National K
idney Foundation, Inc.